SI-BONE Valuation Multiples

SI-BONE Overview

About SI-BONE

SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Founded

2008

HQ

Employees

559

Website

si-bone.com

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $208M

EBITDA: $9M

EV

$582M

Valuation Multiples

Multiples.vc

Start free trial

SI-BONE Financials

SI-BONE reported last 12-month revenue of $208M and EBITDA of $9M.

In the same LTM period, SI-BONE generated $165M in gross profit, $9M in EBITDA, and had net loss of ($20M).

SI-BONE P&L

In the most recent fiscal year, SI-BONE reported revenue of $201M and EBITDA of $9M.

SI-BONE expects next 12-month revenue of XXX and NTM EBITDA of XXX

SI-BONE Stock Performance

SI-BONE has current market cap of $693M, and enterprise value of $582M.

SI-BONE's stock price is $15.70.

SI-BONE Valuation Multiples

SI-BONE trades at 2.8x EV/Revenue multiple, and 62.8x EV/EBITDA.

SI-BONE Financial Valuation Multiples

As of April 1, 2026, SI-BONE has market cap of $693M and EV of $582M.

Equity research analysts estimate SI-BONE's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

SI-BONE has a P/E ratio of (34.9x).

SI-BONE Margins & Growth Rates

SI-BONE's revenue in the last 12 month grew by 15%.

SI-BONE's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.

SI-BONE's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

SI-BONE's rule of X is 41% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

SI-BONE Public Comps

See public comps and valuation multiples for other Medical Devices comps.

SI-BONE M&A Activity

SI-BONE acquired XXX companies to date.

Last acquisition by SI-BONE was on XXXXXXXX, XXXXX. SI-BONE acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

SI-BONE Investment Activity

SI-BONE invested in XXX companies to date.

SI-BONE made its latest investment on XXXXXXXX, XXXXX. SI-BONE invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).